AUSTIN, Texas & MONTREAL--(BUSINESS WIRE)--Forbius, a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer, announced today that the Phase 1a solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback